Royal Bank of Canada’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,462
Closed -$353K 7252
2023
Q2
$353K Buy
3,462
+1,511
+77% +$154K ﹤0.01% 3827
2023
Q1
$177K Sell
1,951
-2,726
-58% -$247K ﹤0.01% 4372
2022
Q4
$178K Buy
4,677
+3,848
+464% +$146K ﹤0.01% 4516
2022
Q3
$20K Buy
829
+539
+186% +$13K ﹤0.01% 5664
2022
Q2
$9K Sell
290
-1,418
-83% -$44K ﹤0.01% 5975
2022
Q1
$56K Sell
1,708
-3,897
-70% -$128K ﹤0.01% 5531
2021
Q4
$148K Buy
5,605
+2,568
+85% +$67.8K ﹤0.01% 5120
2021
Q3
$305K Buy
3,037
+1,126
+59% +$113K ﹤0.01% 4274
2021
Q2
$271K Sell
1,911
-12,756
-87% -$1.81M ﹤0.01% 4341
2021
Q1
$1.46M Buy
14,667
+14,238
+3,319% +$1.42M ﹤0.01% 2875
2020
Q4
$53K Buy
429
+204
+91% +$25.2K ﹤0.01% 5098
2020
Q3
$22K Sell
225
-12,849
-98% -$1.26M ﹤0.01% 5181
2020
Q2
$2.04M Buy
13,074
+6,035
+86% +$942K ﹤0.01% 2267
2020
Q1
$1.02M Buy
7,039
+6,562
+1,376% +$947K ﹤0.01% 2641
2019
Q4
$98K Buy
477
+277
+139% +$56.9K ﹤0.01% 4511
2019
Q3
$16K Sell
200
-204
-50% -$16.3K ﹤0.01% 4997
2019
Q2
$38K Sell
404
-150
-27% -$14.1K ﹤0.01% 4719
2019
Q1
$47K Buy
554
+22
+4% +$1.87K ﹤0.01% 4529
2018
Q4
$30K Sell
532
-337
-39% -$19K ﹤0.01% 4686
2018
Q3
$71K Buy
869
+330
+61% +$27K ﹤0.01% 4459
2018
Q2
$18K Buy
539
+438
+434% +$14.6K ﹤0.01% 5006
2018
Q1
$2K Sell
101
-27
-21% -$535 ﹤0.01% 5527
2017
Q4
$4K Sell
128
-1,003
-89% -$31.3K ﹤0.01% 5393
2017
Q3
$35K Buy
1,131
+1,065
+1,614% +$33K ﹤0.01% 4891
2017
Q2
$2K Sell
66
-129
-66% -$3.91K ﹤0.01% 5550
2017
Q1
$4K Buy
195
+154
+376% +$3.16K ﹤0.01% 5614
2016
Q4
$1K Buy
+41
New +$1K ﹤0.01% 5804